Oropharyngeal cancer treatment: The role of transoral surgery

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 23, Issue 2, 2015, Pages 132-138

  Hinni, Michael L ^a   Nagel, Thomas ^b   Howard, Brittany ^a  

^a MAYO CLINIC HOSPITAL   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Oropharynx; Squamous cell carcinoma; Transoral laser microsurgery; Transoral robotic surgery; Transoral surgery

Indexed keywords

CANCER ADJUVANT THERAPY; CHEMORADIOTHERAPY; CONSERVATIVE TREATMENT; EPIDEMIC; HUMAN; MICROSURGERY; ORAL SURGERY; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROBOT ASSISTED SURGERY; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; TRANSORAL LASER MICROSURGERY; TRANSORAL ROBOTIC SURGERY; TRANSORAL SURGERY; WART VIRUS; CARCINOMA, SQUAMOUS CELL; LOW LEVEL LASER THERAPY; MOUTH; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; ROBOTIC SURGICAL PROCEDURE;

CARCINOMA, SQUAMOUS CELL; HUMANS; LASER THERAPY; MICROSURGERY; MOUTH; NATURAL ORIFICE ENDOSCOPIC SURGERY; OROPHARYNGEAL NEOPLASMS; ROBOTIC SURGICAL PROCEDURES;

EID: 84937878342     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0000000000000143     Document Type: Review

References (53)

1. Green H. A treatise on diseases of the air passages. New York, NY: John Wiley/Putnam; 1846.
2. Killian G. Uber direkte bronchoskopie [By direct bronchoscopy]. Munchen Med Wochonschr 1898; 45:844-847.
3. Killian G. Die Schwebelaryngoskopie [The suspension laryngoscopy]. Arch Laryngol Rhind 1912; 26:277-217.
4. Scalco AN, Shipman WF, Tabb HG. Microscopic suspension laryngoscopy. Annn Otol Rhinol Laryngol 1960; 69:1134-1138.
5. Strong MS, Jako GJ. Laser surgery of the larynx: early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol 1972; 81:791-798.
6. Steiner W. Experience in endoscopic laser surgery of malignant tumors of the upper aerodigestive tract. Adv Otorhinolaryngol 1988; 39:135-144.
7. Grant DG, Salassa JR, Hinni ML. Carcinoma of the tongue base treated by transoral laser microsurgery, part one: untreated tumors-a prospective analysis of oncologic and functional outcomes. Laryngoscope 2006; 117:2150-2155.
8. O'Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116:1465-1472.
9. Desai SC, Sung CK, Jang DW, Genden EM. Tansoral robotic surgery using a carbon dioxide flexible laser for tumors of the upper aerodigestive tract. Laryngoscope 2008; 118:2187-2189.
10. Hinni ML, Lott DG. Contemporary transoral surgery for primary head and neck cancer. San Diego, CA: Plural Publishing, Inc; 2014.
11. Hinni ML, Zarka MA, Hoxworth JM. Margin mapping in transoral surgery for head and neck cancer. Laryngoscope 2013; 123:1190-1198.
12. Van Abel KM, Moore EJ, Carlson ML, et al. Transoral robotic surgery using the thulium:YAG laser: a prospective study. Arch Otolaryngol Head Neck Surg 2012; 138:158-166.
13. Pollei TR, Hinni ML, Moore EJ. Analysis of postop bleeding and risk factors in transoralsurgeryoftheoropharynx.JAMA Otolaryngol2013;139:1212-1218.
14. Quon H, Cohen MA, Montone KT, et al. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope 2013; 123:635-640.
15. Cohen MA, Weinstein GS, O'Malley BW Jr, et al. Transoral robotic surgery and human papillomavirus status: Oncologic results. Head Neck 2011; 33:573-580.
16. Grant DG, Hinni ML, Salassa JR, et al. Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. Arch Otolaryngol Head Neck Surg 2009; 135:1225-1230.
17. Haughey BH, Hinni ML, Salassa JR, et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011; 33:1683-1694.
18. Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16 oropharyngeal cancer. Laryngoscope 2012; 122:S13-33.
19. Chepaha DB, Saccs AG, Erikson VR, et al. Oropharyngoplasty with template based reconstruction of oropharynx defects. Arch Otolaryngol Head Neck Surg 2009; 135:887-894.
20. Zafereo ME, Weber RS, Lewin JS, et al. Complications and functional outcomes following complex oropharyngeal reconstruction. Head Neck 2010; 32:1003-1011.
21. Dziegielewski PT, Mlynarek AM, Dimitry J, et al. The mandibulectomy: friend or foe? Safety outcomes and literature review. Laryngoscope 2009; 119:2369-2375.
22. Williams CE, Kinshuck AJ, Derbyshire SG, et al. Transoral laser resection versus lip-split mandibulotomy in the management of oropharyngeal squamous cell carcinoma (OPSCC): a case match study. Eur Arch Otorhinolaryngol 2014; 271:367-372.
23. Tsue TT, Desyatnikova SS, Deleyiannis FW, et al. Comparison ofcost and functioninreconstructionoftheposterior oralcavityandoropharynx.Freevs.pedicled soft tissue transfer. Arch Otolaryngol Head Neck Surg 1997; 123:731-737.
24. Lee SY, Park YM, Byeon HK, et al. Comparison of oncological and functional outcomes after transoral robotic lateral oropharyngectomy versus lip conventional surgery for T1-T3 tonsillar cancer. Head Neck 2014; 36:1138-1145.
25. Paleri V, Carding P, Chatterjee S, et al. Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: a prospective study. Head Neck 2012; 34:1747-1752.
26. Rich JT, Milou S, Lewis JS, et al. Transoral laser microsurgery /-adjuvant therapy for advanced staged oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 2009; 119:1709-1719.
27. Seikaly H, Rieger J, Wolfaardt J, et al. Functional outcomes after primary oropharyngeal cancer resection and reconstruction with the radial forearm free flap. Laryngoscope 2003; 113:897-904.
28. Garden AS, Harris J, Trotti A. Long term result of concomitant radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase two trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 2008; 72:1351-1355.
29. Diaz-Molina JP, Rodrigo JP, Alvarez-Marcos C, et al. Functional and oncological results of nonsurgical vs surgical treatment in squamous cell carcinomas of the oropharynx. Acta Otorrinolaringol Esp 2012; 63:348-354.
30. Chen AM, Daly ME, Luu Q, et al. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck 2014. [Epub ahead of print]
31. Patel SH, Hinni ML, Hayden RE, et al. Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience. Head Neck 2014; 36:220-225.
32. Moore EJ, Olsen SM, Laborde RR, et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc 2012; 87:219-225.
33. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24-35.
34. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharyngeal cancer: response and survival positively associated with HPV 16 copy number. J Clin Oncol 2008; 26:3138-3146.
35. Cmelak AJ, Li S, Goldwasser MA, et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of eastern cooperative oncology group study E2399. J Clin Oncol 2007; 25:3971-3977.
36. Cmelak AJ, Murphy BA, Burkey B, et al. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multiinstitutional trial. Head Neck 2007; 29:315-324.
37. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010; 28:4142-4148.
38. Rischin D, Peters LJ, O'Sullivan B, et al. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02 HeadSTART): a phase iii trial of the trans-tasman radiation oncology group. J Clin Oncol 2010; 28:2989-2995.
39. Posner MR, Lorch JH, Goloubeva O, et al. Survival and Human Papillomavirus in Oropharynx Cancer in TAX 324: a subset analysis from an international Phase III trial. Ann Oncol 2011; 22:1071-1077.
40. Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a university of pennsylvania phase ii trial. J Clin Oncol 2002; 20:3964-3971.
41. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 french head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22:69-76.
42. Yom SS, Machtay M, Beil MA, et al. Survival impact of planned restaging and early sugical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Amer J Clin Oncol 2005; 28:385-392.
43. Urba SG, Moon J, Shankar Giri PG, et al. Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial. J Clin Oncol 2005; 23:88-95.
44. Greven KM, White DR, Browne JD, et al. Swallowing dysfunction isacommon sequelae after chemoradiation for oropharynx carcinoma. Am J Clin Oncol 2008; 31:209-212.
45. Nguyen NP, Vos P, Smith HJ, et al. Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 2007; 28:3-8.
46. Huang K, Xia P, Chuang C, et al. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer 2008; 113:497-507.
47. Moore EJ, Hinni ML, Olsen KD, et al. Cost considerations in the treatment of oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2012; 146:946-951.
48. Sinha P, Lewis JS, Piccirillo JF, et al. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 2012; 118:3519-3530.
49. Maxwell JH, Ferris RL, Gooding W, et al. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer 2013; 119:3302-3308.
50. Rahmati R, Dogan S, Pyke O, et al. Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation. Head Neck 2014. [Epub ahead of print]
51. Geiger JL, Lazim AF, Walsh FJ, et al. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma. Oral Oncol 2014; 50:311-318.
52. Forastiere AA, Zhang Q, Weber RS, Maor MH, et al. Long-term resultsofRTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013; 31:845-852.
53. Stokley S, Jeyarajah J, Yankey D, et al. Human papillomavirus vaccination cover age among adolescents 2007-2013, and postlicensure vaccine safety monitoring 2006-2014-United States. MMWR Morb Mortal Wkly Rep 2014; 63:620-624.